Electromed, Inc.

132 articles about Electromed, Inc.

• Electromed, Inc. Announces Home Medical Equipment Distributor Partnerships

  8/21/2019

  Electromed, Inc. (NYSE American: ELMD) today announced entry into agreement with two Home Medical Equipment (“HME”) distributors – one national and one regional – to distribute and sell the SmartVest® Airway Clearance System in the United States home care marke

• Electromed, Inc. Names John Erb and Greg Fluet to its Board of Directors

  8/15/2019

  We are pleased to have attracted two experienced executives from the medical device industry who will bring a wealth of relevant expertise

• Electromed, Inc. Schedules Release of Fourth Quarter Fiscal 2019 Financial Results and Conference Call

  8/13/2019

  Electromed, Inc. announced that it will issue its financial results press release for the fiscal 2019 fourth quarter ended June 30, 2019 on Tuesday, August 27, 2019 after the close of the stock market.

• First-Of-Its-Kind Independent Study Finds SmartVest® Reduces Exacerbations, Antibiotic Use, and Stabilizes Lung Function as Part of a Treatment Algorithm

  6/27/2019

  The study also demonstrated stability of lung function post algorithm-based treatment, suggesting early initiation of high frequency chest wall oscillation therapy may slow the otherwise normal progression of the disease.

• Electromed, Inc. Announces Fiscal 2019 Third Quarter Financial Results

  5/7/2019

  Net revenue increased 3.4% to $7.4 million from $7.2 million during the three months ended March 31, 2018

• Electromed, Inc. Names Bud Reeves Vice President of Sales

  4/25/2019

  Electromed, Inc. (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Bud Reeves has joined the Company as Vice President of Sales and will oversee all domestic sales initiatives to accelerate revenue growth.

• Electromed, Inc. Schedules Release of Third Quarter Fiscal 2019 Financial Results and Conference Call

  4/24/2019

  Electromed, Inc. (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2019 third quarter ended March 31, 2019 on Tuesday, May 7, 2019 after the close of the stock market.

• Electromed, Inc. To Participate in the Sidoti & Company Spring 2019 Conference

  3/14/2019

  Management will participate in the Sidoti & Company Spring 2019 Conference in New York, NY on Thursday, March 28, 2019.

• Electromed, Inc. Announces Fiscal 2019 Second Quarter Financial Results

  2/12/2019

  Electromed, Inc. announced financial results for the three months ended December 31, 2018 (Q2 FY 2019).

• Electromed, Inc. Schedules Release of Second Quarter Fiscal 2019 Financial Results and Conference Call

  1/30/2019

  Electromed, Inc. announced that it will issue its financial results press release for the fiscal 2019 second quarter ended December 31, 2018 on Tuesday, February 12, 2019 after the close of the stock market.

• Electromed, Inc. Announces Fiscal 2019 First Quarter Financial Results

  11/13/2018

  Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended September 30, 2018 (“Q1 FY 2019”).

• Electromed, Inc. Schedules Release of First Quarter Fiscal 2019 Financial Results and Conference Call

  10/31/2018

  Management will host a conference call on Wednesday, November 14, 2018 at 9:00 a.m. Eastern Time to discuss the results.

• Electromed, Inc. Announces Fiscal 2018 Fourth Quarter Financial Results

  9/25/2018

  14.8% year-over-year increase in home care revenue

• Electromed, Inc. Announces Results of an Independent Clinical Study: Bronchiectasis Exacerbations Reduced, Lung Function Stabilized with SmartVest®

  8/14/2018

  Electromed, Inc. (NYSE American:ELMD) today announced the results of an independent, outcome-based clinical study presented during the third annual World Bronchiectasis Conference in Washington D.C.

• Electromed, Inc. Announces Fiscal 2018 Third Quarter Financial Results

  5/8/2018

  Net revenue increased 6.3% to $7.1 million from $6.7 million during the three months ended March 31, 2017

• Electromed, Inc. Announces Results of a Longitudinal Outcome-Based Study: Bronchiectasis Exacerbations Significantly Reduced with HFCWO Therapy

  4/26/2018

  Electromed, Inc. announced the results of a longitudinal outcome-based study published in Respiratory Therapy: The Journal of Pulmonary Technique.

• Electromed, Inc. Announces Fiscal 2018 Second Quarter Financial Results

  2/14/2018

  Net revenue increased 9.6% to $7.0 million in Q2 FY 2018 from $6.4 million in Q2 FY 2017, driven by higher home care revenue.

• Electromed, Inc. Schedules Release of Second Quarter Fiscal 2018 Financial Results and Conference Call

  2/1/2018

  Electromed announced that it will issue its financial results press release for the fiscal 2018 second quarter ended December 31, 2017 on Tuesday, February 13, 2018 after the close of the stock market.

• Electromed Announces Fiscal 2018 First Quarter Financial Results

  11/8/2017

  Gross profit rose 14.1% to $4.9 million from $4.3 million in Q1 FY 2017.

• Electromed, Inc. Schedules Release of First Quarter Fiscal 2018 Financial Results and Conference Call

  10/26/2017

  Electromed announced that it will issue its financial results press release for the fiscal 2018 first quarter ended September 30, 2017 on Tuesday, November 7, 2017 after the close of the stock market.